Gastroentological device developers Sandhill Scientific and Medovations announced today they will merge and take on their holding company’s name, operating as Diversatek Healthcare.
The merger will combine Medovation’s portfolio of endoscopy products and Sandhill Scientific’s diagnostic solutions focused on esophageal motility disorders, anorectal motility disorders and gastroesophageal reflux disease, the companies said.
“Personalized service, best-in-class clinical education, and an untiring dedication to science will continue to differentiate Diversatek Healthcare. We have large company resources yet maintain our commitment to personal connections with our customers. Every product concept begins with an understanding of clinical and patient needs, and that’s ultimately how we measure our achievements,” Diversatek Healthcare prez & CEO Meg Vierling said in a press release.
The companies will function as a single organization, and combined, will “heighten its ongoing commitment to research,” according to the press release.
“Our singular goal is to continue to build a focused organization rooted in technology, innovation, efficiency, accountability and attentiveness. We feel that the combined portfolios provide a unique offering of therapeutic devices, accessories, and highly specialized diagnostics that enable our customers to provide exceptional care. We look forward to supplementing our current product portfolio as a result of shared resources and access to broader technologies,” parent company Diversatek Inc chair & CEO Brant Stanford said in a prepared statement.
Medovations has operated as a subsidiary of Diversatek since 1983, and acquired Sandhill Scientific in 2013.
